Dr. William Foulkes, an expert in cancer genetics and a senior investigator at the Lady Davis Institute, has received the 2020 Wilder Penfield Prize for his research.
Dr. Mark Basik, a surgical oncologist at the JGH and a senior investigator in the Lady Davis Institute, has been appointed President of the Scientific Advisory Committee of the Cancer Research Society.
Approximately 3,011 people streamed through the streets of Montreal in August 2005 in the first Weekend to End Breast Cancer, giving a major boost to the treatment and prevention of breast cancer at the Segal Cancer Centre.
Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.
One of Hope & Cope’s newest initiatives, the Breast & Bone Health Program, identifies women who have had breast cancer and are at risk for bone fragility.
It is unjustified and potentially harmful to screen women for genes whose connection to breast cancer has yet to be proven, says an international team of leading geneticists and oncologists.